NCT06720857View on ClinicalTrials.gov

Predictive Value of SFlt-1/PlGF Ratio for the Diagnosis of Cardiovascular Disorders in the Puerperium: Pilot Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

April 6, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Cardiovascular DisorderPuerperium; Disease
Interventions
DIAGNOSTIC_TEST

Identification of a risk stratification model and its predictive value for cardiovascular disorders in the puerperium

Identification of a risk stratification model for cardiovascular/hypertensive disorders in the puerperium using a panel of placental biochemical markers (sFlt-1 and PlGF: already used in pregnancy for prediction of preeclampsia), demographic, clinical and laboratory data.

Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER